{"altmetric_id":2282098,"counts":{"readers":{"mendeley":13,"citeulike":0,"connotea":0},"blogs":{"unique_users_count":1,"unique_users":[58719],"posts_count":1},"total":{"posts_count":2},"twitter":{"unique_users_count":1,"unique_users":["hswapnil"],"posts_count":1}},"selected_quotes":[". @signindoc @ChristosArgyrop @nephondemand From DOPPS, across Canada patients prefer CVC over AVG"],"citation":{"abstract":"Catheters are associated with worse clinical outcomes than fistulas and grafts in hemodialysis (HD) patients. One potential modifier of patient vascular access (VA) use is patient preference for a particular VA type. The purpose of this study is to identify predictors of patient VA preference that could be used to improve patient care.","abstract_source":"pubmed","altmetric_jid":"4f6fa62b3cf058f610007f15","authors":["Fissell RB","Fuller DS","Morgenstern H","Gillespie BW","Mendelssohn DC","Rayner HC","Robinson BM","Schatell D","Kawanishi H","Pisoni RL"],"doi":"10.5301\/jva.5000140","first_seen_on":"2014-04-15T21:50:31+00:00","issns":["1129-7298"],"issue":"0","journal":"The Journal of Vascular Access","last_mentioned_on":1442491200,"links":["http:\/\/www.ncbi.nlm.nih.gov\/m\/pubmed\/23599135\/","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23599135"],"pmid":"23599135","pubdate":"2013-04-21T00:00:00+00:00","scopus_subjects":["Medicine","Health Sciences"],"title":"Hemodialysis patient preference for type of vascular access: variation and predictors across countries in the DOPPS.","type":"article","volume":"0","mendeley_url":"http:\/\/www.mendeley.com\/research\/hemodialysis-patient-preference-type-vascular-access-variation-predictors-across-countries-dopps"},"altmetric_score":{"score":7.33,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":7.33},"context_for_score":{"all":{"total_number_of_other_articles":6360434,"mean":5.8378713181954,"rank":802358,"this_scored_higher_than_pct":87,"this_scored_higher_than":5557046,"rank_type":"exact","sample_size":6360434,"percentile":87},"similar_age_3m":{"total_number_of_other_articles":134523,"mean":8.0840751549934,"rank":22579,"this_scored_higher_than_pct":83,"this_scored_higher_than":111922,"rank_type":"exact","sample_size":134523,"percentile":83},"this_journal":{"total_number_of_other_articles":206,"mean":0.57224390243902,"rank":1,"this_scored_higher_than_pct":99,"this_scored_higher_than":205,"rank_type":"exact","sample_size":206,"percentile":99},"similar_age_this_journal_3m":{"total_number_of_other_articles":8,"mean":0.56428571428571,"rank":1,"this_scored_higher_than_pct":87,"this_scored_higher_than":7,"rank_type":"exact","sample_size":8,"percentile":87}}},"demographics":{"poster_types":{"member_of_the_public":1},"users":{"twitter":{"cohorts":{"Members of the public":1}},"mendeley":{"by_status":{"Unspecified":1,"Librarian":1,"Researcher":3,"Student  > Ph. D. Student":2,"Student  > Postgraduate":2,"Student  > Master":1,"Student  > Bachelor":1,"Lecturer > Senior Lecturer":1,"Professor":1},"by_discipline":{"Medicine and Dentistry":9,"Psychology":2,"Unspecified":2}}},"geo":{"twitter":{"CA":1},"mendeley":{"CA":2,"US":1}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/hswapnil\/status\/456187804507066368","license":"datasift","citation_ids":[2282098],"posted_on":"2014-04-15T21:50:22+00:00","author":{"name":"Swapnil Hiremath, MD","url":"http:\/\/about.me\/swapnil.hiremath","image":"https:\/\/pbs.twimg.com\/profile_images\/730502747754139649\/hP6Q9DDQ_normal.jpg","description":"Nephrologist, Mumbai|Boston|Ottawa. #NephJC cofounder. Work at @ottawahospital @uottawamed @ottawarenal Opinions personal etc\/No pharma conflicts","id_on_source":"hswapnil","tweeter_id":"23789628","geo":{"lt":45.41117,"ln":-75.69812,"country":"CA"},"followers":3910},"tweet_id":"456187804507066368"}],"blogs":[{"title":"US Versus the World on Vascular Access Trends: Where Do We Stand?","url":"http:\/\/ajkdblog.org\/2015\/09\/17\/us-versus-the-world-on-vascular-access-trends-where-do-we-stand\/","license":"public","citation_ids":[3847559,4525692,4525693,2282098,4094967,4525694],"posted_on":"2015-09-17T12:00:00+00:00","summary":"Copyright: hfsimaging \/ 123RF Stock Photo\nVascular access choices in end-stage renal disease (ESRD) patients depend on a number of factors. A recent update was published in AJKD from the US DOPPS Practice Monitor with international comparisons.&nbsp; Corre","author":{"name":"AJKD Blog","url":"http:\/\/ajkdblog.org\/","description":"The Official Blog of the American Journal of Kidney Diseases"}}]}}